In this study, we demonstrated that serum hepcidin levels are strongly associated with subclinical atherosclerosis, as assessed by carotid intima–media thickness (CIMT), in patients undergoing peritoneal dialysis (PD). Here, HAMP is linked to atherosclerosis.